Navigation Links
BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014
Date:7/31/2014

BOTHELL, Wash., July 31, 2014 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced today that the Company's second quarter 2014 financial results will be released on Thursday, August 7, 2014, and that the Company will host a conference call and live webcast at 4:30 p.m. ET that afternoon. Management will provide an overview of the Company's financial results and a general business update.

To access the webcast, log on to the Investor Relations page of the BioLife Solutions website at www.biolifesolutions.com. Alternatively, you may access the live conference call by dialing (844) 825-0512 (U.S. & Canada) or (315) 625-6880 (International) with the following Conference ID:
82507281. A webcast replay will be available approximately two hours after the call and will be archived on www.biolifesolutions.com for 90 days.

About BioLife SolutionsBioLife Solutions develops, manufactures and markets hypothermic storage and cryopreservation solutions for cells, tissues, and organs. The Company's proprietary HypoThermosol® and

SOURCE BioLife Solutions, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
2. BioLife Solutions 2011 Revenue Up 33%
3. BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board
4. Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION
5. BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite
6. BioLife Solutions Announces 2012 Second Quarter Results: Eighth Straight Quarter of Record Revenue
7. BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference
8. BioLife Solutions Announces 2012 Third Quarter Results: Ninth Straight Quarter of Record Revenue
9. BioLife Solutions Announces License Agreement
10. BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013
11. BioLife Solutions Named One of Washingtons Best Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... REDWOOD CITY, Calif. , Sept. 3, 2015 ... announced today that five abstracts highlighting the performance ... patients have been accepted for oral and poster ... of Lung Cancer,s 16th World Conference on Lung ... Cancer Center; the University of California, Davis; the ...
(Date:9/3/2015)... -- According to a new market research ... Flash), GC, Other Components (Autosamplers, Detectors, Fraction Collectors), by ... & Global Forecasts to 2020", published by MarketsandMarkets, The ... Billion by 2020 from USD 7.062 Billion in 2015, ... tables and 36 figures spread through 277 Pages and ...
(Date:9/2/2015)... HAMILTON, Bermuda , Sept. 2, 2015 Axovant ... on the treatment of dementia, today announced upcoming presentations at ... 4:55 PM at the Baird 2015 Healthcare Conference in ... hotel , Thursday, September 10 at 2:00 PM at ... at the Millennium Broadway Hotel & Conference Center ...
(Date:9/2/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report "Biochips and ... their offering. This report is an ... applications. The report starts with a description of ... Technologies include array comparative genomic hybridization (CGH), copy ...
Breaking Biology Technology:Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 2Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 3Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 4Chromatography Instruments Market Worth $ 9.223 Billion by 2020 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 4Axovant Sciences To Present At Upcoming Investor Conferences 2Axovant Sciences To Present At Upcoming Investor Conferences 3Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2
... Masimo (Nasdaq: MASI ) ... accuracy and value of its noninvasive and continuous hemoglobin ... the Society of Critical Care Medicine (SCCM) Annual ... multi-professional critical care event of the year, the SCCM ...
... Soligenix, Inc. (OTC Bulletin Board: SNGX ... announced today that the US Food and Drug Administration ... the prevention of ricin intoxication.  RiVax™ is a proprietary ... chain of ricin toxin which induces ricin neutralizing antibodies ...
... new image and cell technologies have for the first ... red blood cells. The researchers, from the Walter and ... of Technology, Sydney (UTS), achieved this long-held aim using ... a technology platform new to Australia. The detailed ...
Cached Biology Technology:New Clinical Study Finds Masimo Noninvasive Hemoglobin Accurate in Patients with Critically Low Hemoglobin Levels 2New Clinical Study Finds Masimo Noninvasive Hemoglobin Accurate in Patients with Critically Low Hemoglobin Levels 3New Clinical Study Finds Masimo Noninvasive Hemoglobin Accurate in Patients with Critically Low Hemoglobin Levels 4New Clinical Study Finds Masimo Noninvasive Hemoglobin Accurate in Patients with Critically Low Hemoglobin Levels 5Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication 2Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication 3Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication 4Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication 5Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication 6Malaria parasite caught red-handed invading blood cells 2Malaria parasite caught red-handed invading blood cells 3
(Date:8/5/2015)... -- According to a new market research ... Vertical (BFSI, Airport, IT & Telecom, Utilities, Education, Defense ... 2020", published by MarketsandMarkets, defines and segments the Physical ... The global PIAM Market is estimated to grow from ... at a CAGR of 14.9 % from 2014 to ...
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 /PRNewswire/ ... ( http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition ... Component (Hardware, Software, and Service), Sub-Segment (Computer ... Cloud Forensics), Tool Types, Service, Vertical and ... report to their offering. By ...
(Date:7/31/2015)... Den 10. internationale konference om Genomik (ICG-10, ... - 25. oktober i Shenzhen , ... i år. Siden starten i 2006 er ICB blevet ... og er en af de mest dynamiske, entusiastiske og ... nylige gennembrud og fremskridt inden for ,omik,-forskning, som yderligere ...
Breaking Biology News(10 mins):Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... who held their breath for several minutes had elevated levels ... a new study from the Journal of Applied Physiology ... and leaves open the question of whether lengthy apnea (breath-holding) ... "The results indicate that prolonged, voluntary apnea affects the integrity ...
... Peter Wilf, associate professor of geosciences, has been ... 2012 by the Paleontological Society. The Paleontological ... other work in paleontology is highly regarded and ... The Lecturers are excellent speakers who communicate the ...
... (August 3, 2009) La Jolla Institute for Allergy ... a role in allergy onset, instead have discovered its ... be important in myeloproliferative diseases and some types of ... disorders characterized by an overproduction of blood cells by ...
Cached Biology News:Holding breath for several minutes elevates marker for brain damage 2Holding breath for several minutes elevates marker for brain damage 3Holding breath for several minutes elevates marker for brain damage 4La Jolla Institute discovers novel tumor suppressor 2La Jolla Institute discovers novel tumor suppressor 3
... Stem Cell Functional Identification Kit contains ... be used for the short-term maintenance, ... the induction of NSCs into astrocyte, ... panel consisting of mouse anti-human Nestin, ...
GM130 Immunogen: Recombinant purified rat GM130 Family / Subclass 1: Signal Transduction Storage: 4 C...
NATIVE RAT OSTEOCALCIN...
... x W x H): 17 3/4" ... lbsCapacity: 12 slidesTime: Programmable 0 - 100 ... and hybridization steps 40 user programmable protocols ... Fixed temperature) Rapid temperature ramp-up from 37 ...
Biology Products: